OptiNose Inc (OPTN) reports a 3% revenue increase and improved prescription metrics, but adjusts full-year guidance due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback